Hologic Inc
HOLXHologic Inc
We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women s health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives.
17.42% operating margin is respectable but not wide. ROIC at 7.75%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue growth slowed to 1.7%, essentially flat. Margins also contracted 4.5pp. This is a business that needs a catalyst.
Free cash flow declined 18% versus the prior year, cash generation momentum has weakened. ROIC dropped from 10.33% to 7.75%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
$4.13B
▲ +1.7% YoY
Net Income (TTM)
$544M
▼ -28.3% YoY
Op. Margin
17.48%
▼ -4.5pp YoY
ROIC
8.04%
▼ -2.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$1.04B
▼ -17.7% YoY
Op. Cash Flow (TTM)
$1.10B
▼ -17.7% YoY
Net Debt
$156M
Cash & Equiv.
$2.36B
5Y CAGR: +1.7%
5Y CAGR: +4.6%
Continue Research
SourceComputed from the 10-Q filed 23 Jan 2026, covering the period ending 27 Dec 2025, as reported to the SEC. Data last refreshed 25 Sept 2026. How this is calculated.
Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically.
Related stocks: X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Spot a number that looks wrong?
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.